Atovaquone and rifabutine-loaded nanocapsules: Formulation studies

International Journal of Pharmaceutics

Volumn 153, Issue 1, 1997, Pages 127-130

  Dalencon F ^a   Amjaud, Y ^a   Lafforgue, C ^a   Derouin, F ^b   Fessi, H ^a  

^a UNIVERSITÉ LYON 1   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Atovaquone; Nanocapsules; Ribabutine; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

ATOVAQUONE; NANOCAPSULE; RIFABUTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUSPENSION; TOXOPLASMOSIS;

EID: 0343852341     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00076-8     Document Type: Article

References (8)

1. Araujo, F.G., Huskinson, J., Remington, J.S., 1991. Remarkable in vitro and in vivo activities of the hydroxynaphtoquinone 556C80 against tachyzoites and tissue cyst of Toxoplasma gondii. Antimicrob. Agent. Chemother. 35, 293-299.
2. Araujo, F.J., Slifert, T., Remington, J.S., 1994. Rifabutine is active in murine models of toxoplasmosis. Antimicrob. Agent. Chemother. 38, 570-575.
3. Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N., Benita, S., 1989. Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm. 55, R1-R4.
4. Kovacs, J.A., 1992. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 340, 637-638.
5. Piketty, C., Derouin, F., Rouveix, B., Pocidalo, J.J., 1990. In vivo assessment of antimicrobial agent against Toxoplasma gondii by quantification of parasites in the blood, lung and brain of infected mice. Antimicrob. Agent. Chemother. 34, 1467-1472.
6. Porter, S.B., Sande, M.A., 1992. Toxoplasmosis of the central nervous system in acquired immunodeficiency syndrome. N. Engl. J. Med. 327, 1643-1648.
7. Remington, J.S., Desmond, G., 1990. Toxoplasmosis. In: Remington, J.S., Klein, J.O. (Eds.), Infectious Diseases of the Fetus and Newborn Infants, W.B. Saunders, Philadelphia, pp. 89-195.
8. Rolan, P.E., Mercer, A.J., Weatherly, B.C., Holdish, H., Meire, M.W., Peck, G., 1994. Examination of some factors responsible for a food induced increase of atovaquone. Br. J. Clin. Pharmacol. 37, 13-20.